Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008
- PMID: 21172005
- PMCID: PMC3020176
- DOI: 10.1186/1471-230X-10-144
Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008
Abstract
Background: A decrease in the need for liver transplantations (LTX) in Primary Biliary Cirrhosis (PBC), possibly related to treatment with ursodeoxycholic acid (UDCA), has been reported in the USA and UK. The aim of this study was to assess LTX requirements in PBC over the past 20 years in the Netherlands.
Methods: Analysis of PBC transplant data of the Dutch Organ Transplant Registry during the period 1988-2008, including both absolute and proportional numbers. The indication for LTX was categorized as liver failure, hepatocellular carcinoma or poor quality of life (severe fatigue or pruritus). Data were analysed for two decades: 1.1.1988-31.12.1997 (1(st)) and 1.1.1998-31.12.2007 (2(nd)). The severity of disease was quantified using MELD scores. To fit lines which show trends over time we applied a linear regression model.
Results: A total of 110 patients (87% women) was placed on the waiting list. 105 patients were transplanted (1(st): 61, 2(nd): 44), 5 (5%) died while listed. The absolute annual number of LTX for PBC slightly decreased during the 20 year period, the proportional number decreased significantly. At the time of LTX the mean age was 53.6 yrs. (1(st): 53.4, 2(nd): 53.8), the mean MELD score 13.9 (1(st):14.5, 2(nd):13.0). The median interval from diagnosis to LTX was 90.5 months (1(st):86.5, 2(nd): 93.5). 69% of patients was treated with UDCA (1(st) 38%, 2(nd) 82%).
Conclusions: Over the past 20 years the absolute number of LTX for PBC in the Netherlands showed a tendency to decrease whereas the proportional decrease was significant. There was a trend over time toward earlier transplantation.
Figures


Similar articles
-
Transplantation trends in primary biliary cirrhosis.Clin Gastroenterol Hepatol. 2007 Nov;5(11):1313-5. doi: 10.1016/j.cgh.2007.07.015. Epub 2007 Sep 27. Clin Gastroenterol Hepatol. 2007. PMID: 17900996
-
Primary biliary cirrhosis in the era of liver transplantation.Ann Transplant. 2014 Sep 29;19:488-93. doi: 10.12659/AOT.890753. Ann Transplant. 2014. PMID: 25262831 Review.
-
Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades.Aliment Pharmacol Ther. 2019 Feb;49(3):285-295. doi: 10.1111/apt.15060. Epub 2018 Dec 18. Aliment Pharmacol Ther. 2019. PMID: 30561112 Free PMC article.
-
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.Liver Transpl. 2007 Sep;13(9):1236-45. doi: 10.1002/lt.21124. Liver Transpl. 2007. PMID: 17763401
-
Current Status of Liver Transplantation for Primary Biliary Cholangitis.Clin Liver Dis. 2018 Aug;22(3):613-624. doi: 10.1016/j.cld.2018.03.011. Clin Liver Dis. 2018. PMID: 30259857 Review.
Cited by
-
Current and Future Burden of Chronic Nonmalignant Liver Disease.Clin Gastroenterol Hepatol. 2015 Nov;13(12):2031-41. doi: 10.1016/j.cgh.2015.08.015. Epub 2015 Aug 17. Clin Gastroenterol Hepatol. 2015. PMID: 26291665 Free PMC article. Review.
-
Serum levels of a cell death biomarker predict the development of cirrhosis-related conditions in primary biliary cholangitis.Med Mol Morphol. 2018 Sep;51(3):176-185. doi: 10.1007/s00795-018-0184-0. Epub 2018 Jan 29. Med Mol Morphol. 2018. PMID: 29380060
-
Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives.World J Hepatol. 2022 Jun 27;14(6):1111-1119. doi: 10.4254/wjh.v14.i6.1111. World J Hepatol. 2022. PMID: 35978669 Free PMC article. Review.
-
Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis.Gastroenterol Hepatol (N Y). 2018 Mar;14(3):154-163. Gastroenterol Hepatol (N Y). 2018. PMID: 29928160 Free PMC article.
-
Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years.Hepatol Int. 2014 Apr;8(2):266-74. doi: 10.1007/s12072-014-9530-z. Epub 2014 Mar 28. Hepatol Int. 2014. PMID: 26202508
References
-
- Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB. et al.Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009;136(4):1281–1287. doi: 10.1053/j.gastro.2009.01.003. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous